Long-Term Retention of Young Adult Study Participants with Youth-Onset Type 2 Diabetes: Results from the TODAY2 Study
Authors' conclusion
In a racially and ethnically diverse population of youth-onset type 2 diabetes, benefits and barriers associated with long-term retention are described. These findings can be used to help inform future retention strategies for young adults in clinical trials.
Study context
- Population
- Young adults with youth-onset T2D who completed the last TODAY2 study visit (63.8% of original TODAY cohort); mean age 27 years, 36% non-Hispanic black, 18% non-Hispanic white, 39% Hispanic, 52% public and 35% private healthcare coverage63.8% of original cohort
- Outcome
- Self-reported benefits of and barriers to staying in the study
Methodological detailsfour-point Likert-type scale
- Four-point Likert-type scale
Main finding
As reported in the abstract
Survey responders agreeing with the benefits listed for staying in TODAY2
More than 93%
Observational data: associations, not effects.
Further findings
Subgroups by healthcare coverage and glycaemic control
- Public healthcare coverage: more likely to endorse diabetes-care benefits and monetary compensation
- Poor glycaemic control: cited "fear of disappointing" study staff as a barrier
Original publication
Long-Term Retention of Young Adult Study Participants with Youth-Onset Type 2 Diabetes: Results from the TODAY2 Study. Horm Res Paediatr. Published 21 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →